title: Compliance with pharmacologic prophylaxis and therapy in bronchial asthma.
abstract: Between January 1 and December 31, 1988, 288 children [185 boys and 103 girls, mean age 8.75 +/- 4.98 years (range 2.50 to 16.83)], followed at the Outpatient Clinic for Lung Diseases of the University of Milan 5th Pediatric Department, were interviewed blindly in order to assess their compliance with pharmacologic therapy. All children were suffering from episodic, frequent, or chronic asthma requiring therapy as needed and preventive drugs for at least 30 days. Prophylaxis (including cromolyn, beclomethasone, theophylline retard, ketotifen, oxatomide, albuterol, and prednisone, alone or in combinations) and therapy in case of symptoms (albuterol, with or without theophylline prompt or beclomethasone) were prescribed. A study questionnaire was completed 30 to 45 days after the prescription with no advance warning by a physician unaware of the prophylactic and therapeutic prescriptions. Out of the 288 patients, 31 (10.8%) failed to return for the second visit. Understanding of prophylaxis was full in 61.1% of cases, partial in 23.3% and nil in 4.9%. Therapy as needed was fully remembered by 77.1% of parents, partially by 9.4% and totally forgotten by 2.8%. Compliance with single-drug prophylaxis was full in 60.1% of cases, partial in 22.2% and nil in 6.4%. Statistical analysis showed compliance was significantly better for ketotifen than for disodium cromoglycate (chi squared 9.85, P < .02), for ketotifen than for theophylline (chi squared 9.98, P < .02), and for beclomethasone than for theophylline (chi squared 8.77, P < .05).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: 5th Pediatric Department, University of Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Fiocchi
authors.forename: F
authors.initials: F
authors.lastname: Alessandro
authors.forename: G V
authors.initials: GV
authors.lastname: Zuccotti
authors.forename: Z G
authors.initials: ZG
authors.lastname: Vincenzo
authors.forename: M
authors.initials: M
authors.lastname: Sala
authors.forename: S
authors.initials: S
authors.lastname: Marco
authors.forename: M
authors.initials: M
authors.lastname: Giovannini
authors.forename: G
authors.initials: G
authors.lastname: Marcello
authors.forename: E
authors.initials: E
authors.lastname: Riva
authors.forename: R
authors.initials: R
authors.lastname: Enrica
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000517:prevention & control*; D001507:Beclomethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D010349:Patient Compliance; D011795:Surveys and Questionnaires; D013806:Theophylline / Q000627:therapeutic use
chemical_list: D001993:Bronchodilator Agents; D006634:Histamine H1 Antagonists; D013806:Theophylline; D001507:Beclomethasone; D004205:Cromolyn Sodium; D000420:Albuterol